Officials at the Association of the British Pharmaceutical Industry are working with members of medical organizations toward financial disclosure rules, similar to the U.S. Sunshine Act, that are likely to be adopted by the European Federation of Pharmaceutical Industries and Associations. The ABPI will hold a consultation to determine how to create and implement a system for disclosing financial relationships with health care providers.

Full Story:

Related Summaries